Why do current safety systems sometimes fail to notice that approved drugs are causing serious adverse effects? And can surveillance methods be improved? Simon Frantz investigates. It's 3 a.m. in a typical US emergency room, and doctors are bustling around a patient in his mid-sixties, one of several admitted that night with severe chest pain. He's anxious, sweating and struggling to breathe — classic symptoms of a heart attack.
展开▼
